Posts by Judit Sánchez Gil, PhD
-
Review: Oncolytic Herpes Simplex Viruses for Treatment of Glioma
Kimia Kardani, PhD, Judit Sánchez Gil, PhD, and Samuel D. Rabkin, PhD, describe in a review how herpes simplex viruses can be engineered to treat cancer safely, and they discuss the current state of oncolytic virus therapy for glioblastoma.
Biography
Judit Sánchez Gil, PhD, is a research fellow in the Molecular Neurosurgery Laboratory in the Department of Neurosurgery at Massachusetts General Hospital.